NEW YORK ( TheStreet) -- CHANGE IN RATINGSArcher-Daniels-Midland ( ADM) was downgraded at BMO Capital. Valuation call, based on a $32 price target, BMO Capital said. Atmel ( ATML) was downgraded at FBR Capital Markets from outperform to market perform. $7.50 price target. Company may lose market share in the near term, FBR Capital Markets said. AZZ ( AZZ) was upgraded from neutral to buy at DA Davidson. Estimates were also boosted, as the recent acquisition should add to earnings. DA Davidson said. Chemtura ( CHMT) was downgraded at Oppenheimer to perform from outperform. Approaching limits to further margin improvement, Oppenheimer said. Colgate-Palmolive ( CL) was downgraded at Bank of America/Merrill Lynch from buy to neutral. $119 price target. Company is facing difficult comps and a currency headwind, BofA/Merrill Lynch said. CVR Refining ( CVRR) was initiated with a neutral rating at Citigroup. $30 price target. Highly defensible position with modest upside, Citi said. CVR Refining LP was initiated with a buy rating at UBS. $31 price target. Yielding fruit of Midwest refining bonanza. Ford ( F) was upgraded to buy at TheStreet Ratings. GM ( GM) was upgraded to buy at TheStreet Ratings. Intel ( INTC) was upgraded at Drexel Hamilton from sell to hold. $22 price target. Altera foundry deal should help future earnings, Drexel Hamilton said. LSI ( LSI) was downgraded at FBR Capital Markets from outperform to market perform. $8 price target. Company is facing increased competition, FBR Capital Market said. Altria ( MO) was downgraded at Bank of America/Merrill Lynch from buy to neutral. $36 price target. Company will likely face increased competition from RAI, BofA/Merrill Lynch said. Rosetta Resources ( ROSE) was downgraded at Miller Tabak to sell. $41 price target. Company is running out of oil inventory, Miller Tabak said. Suntrust Banks ( STI) was upgraded at FIG Partners to outperform. $32 price target. Expect positive results from the CCAR stress test, FIG Partners said.
STOCK COMMENTS / EPS CHANGESAutodesk ( ADSK) estimates, price target were raised at Credit Suisse. Shares are now seen reaching $35. Estimates were also increased, as the company is signing more large deals, Credit Suisse said. Amgen ( AMGN) estimates, target boosted at Guggenheim. Shares are now seen reaching $95. Estimates were also increased, as Epogen is facing less competition, following the Omontys recall, Guggenheim said. Neutral rating. Best Buy ( BBY) price target was raised at UBS. Shares are now seen reaching $18. Prolonged stability is now needed to justify BBY's price move, UBS said. Neutral rating. Chuy's Holdings ( CHUY) numbers were raised at Jefferies. Shares are now seen reaching $25. Estimates were also raised on unit growth. Hold rating. Capital One Financial ( COF) numbers were lowered at Jefferies. Shares are now seen reaching $60. Estimates were also lowered on Best Buy card portfolio sale. Buy rating. Darden Restaurants ( DRI) numbers were lowered at Oppenheimer. Shares are now seen reaching $51. Estimates were also lowered on uncertainty surrounding EPS growth, Oppenheimer said. Outperform rating. FirstEnergy ( FE) numbers were cut at Credit Suisse. Shares are now seen reaching $46. Estimates were also reduced, as the company will likely issue more equity later this year, Credit Suisse said. Outperform rating. JM Smucker ( SJM) numbers were increased at Keybanc. Estimates were raised through 2014. Company is focused on organic growth and improving efficiency, Keybanc said. Buy rating and new $100 price target. >To submit a news tip, email: firstname.lastname@example.org.
Twitter and become a fan on Facebook.